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ABSTRACT 
In the last ten years, there has been little advancement in the treatment of the aggressive 
brain cancer Glioblastoma Multiforme (GBM). This work describes the synthesis of a 
superparamagnetic iron oxide (SPION)-based nanotheraputic complex for use in 
targeting and killing aggressive mesenchymal GBM cells. The average sizes (and 
therefore magnetic properties) of the synthesized SPIONs are precisely tailored via a 
novel time-controlled approach utilizing a previously described electrochemical reaction. 
Through this synthetic method, the optimal particle size (OPS) where maximal thermal 
energy is released upon stimulation with an external magnetic field was determined to be 
21 nm. The nano-complex was further modified to selectively target GBM cells by 
adding a heterobifunctional poly(ethylene) glycol polymer cross-linked to TWEAK (a 
GBM targeting ligand). Further investigation with FITC Annexin V/Propidium Iodide 
fluorescent probe and transmission electron microscopy showed that cells treated with the 
synthesized nano-complex showed both biochemical and morphological markers positive 
for programmed cell death. Thus, these nano-complexes show promise as a potential 
treatment agent for an otherwise untreatable disease. 
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LIST OF ABBREVIATIONS 
BBB: blood brain barrier 
CoV: coefficient of variation 
E: anisotropic energy barrier 
EB: anisotropic energy constant (4.6 kJ m-3 for maghemite) 
DMAP: 4-dimethylaminopyridine 
DMPAP: 2,2-dimethoxy-2-phenylacetophenone 
DNA: deoxyribonucleic acid 
DOX: doxorubicin 
EDC: 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EGFR: epidermal growth factor receptor 
EMR: electromagnetic radiation 
EPR: enhanced permeability and retention effect 
f0: ferromagnetic resonance frequency (~1 GHz) 
h: liquid dynamic viscosity 
H: external magnetic field 
HIF1A: hypoxia-inducible factor 1a 
1HNMR: proton nuclear magnetic resonance 
ICP: intracranial pressure 
IR: infrared 
J: angular momentum quantum number 
kb: Boltzmann’s constant (1.38x10-23 J/K) 
KD: dissociation constant 
GBM: Glioblastoma Multiforme 
l: wavelength (of light) 
l: angular momentum 
µ: magnetic dipole moment 
M: magnetization 
mAb: monoclonal antibody 
MES: 2-(N-morpholino)ethanesulfonic acid 
MGMT: O6-methylguanine-DNA methyltransferase 
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NF-kB: k-light chain enhancer of activated B cells pathway 
PBS: phosphate buffered saline 
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PS: phosphatidylserine 
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rh: hydrodynamic radius 
RT: room temperature 
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s: spin angular momentum 
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SPION: Superparamagnetic Iron Oxide Nanoparticle 
Sulfo-NHS: N-hydroxysulfosuccinimide 
tB: Brownian rotation frequency 
tN: Neel rotation frequency 
T: temperature 
t=time 
TEM: transmission electron microscope 
TNF: tumor necrosis factor 
TRAF: TNFR-associated factor 
TWEAK: TNF-like weak inducer of apoptosis 
V: (particle) volume 
VEGF: vascular endothelial growth factor 
VEGF-R: vascular endothelial growth factor receptor 
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Introduction 
Glioblastoma Multiforme: Pathology and Molecular Pathogenesis  
Brain cancers represent a clinically diverse, unique, and deadly set of tumors. 
Within the brain there exist two main classes of cells: neurons and glial cells. By far, 
most primary intrinsic tumors diagnosed are cancers of glial cells, otherwise referred to 
as gliomas. Within the glioma subcategory, Glioblastoma Multiforme (GBM) is the most 
prevalent, accounting for 56.1% of all diagnosed gliomas between the years 2012-2016.1 
Pathologically, these tumors are defined by having a diverse intratumoral morphology 
with areas high vascularity mirroring areas of tissue necrosis. At the cellular level, GBM 
displays high cellularity, nuclear atypia, polynucleism, and increased mitotic activity.2-4 
The patterns of the molecular pathogenesis in GBM mimic those traditionally seen in 
other types of aggressive cancer. Hallmark alterations includes overexpression and 
mutations of the following proteins (among many others): epidermal growth factor 
receptor (EGFR), O6-methylguanine-DNA methyltransferase (MGMT), hypoxia-
inducible-factor-1-alpha (HIF1A), and vascular endothelial growth factor (VEGF) and 
numerous Tumor Necrosis Factor (TNF) superfamily proteins.2,3  
Overall, the net effect of these alterations acts to increase the ability of the 
cancerous cells to survive and proliferate within healthy parenchymal tissue. Healthy 
neural tissue is affected in one of two ways due to this tumor. First, healthy tissue is 
directly destroyed through exposure of pro-inflammatory agents leaked from neoplastic 
cells such as cytokines and chemokines. This results in focal neural deficits typically seen 
in patients suffering from strokes. Second, increased tumor size leads to increased 
vasogenic edema which in turn leads to increased intracranial pressure (ICP). Increased 
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ICP has the capacity to cause devastating negative effects to the brain centers responsible 
for maintaining our ability to survive.5 Even with the most aggressive and concurrent 
treatments available in modern medicine, the median survival time of patients with GBM 
is 12-15 months. This survival time has not significantly changed over the last 10 years.2,6 
Glioblastoma Multiforme: Current Treatments and Challenges 
 The traditional first-line chemotherapeutic treatment for malignant primary 
intracranial gliomas has been Temozolomide. Temozolomide (Figure 1) is a small, 
nonpolar imidazotetrazine derivative of dacarbazine (a DNA alkylating agent) with a 
unique ability of being able to cross the blood brain barrier (BBB).  
 
Figure 1: The chemical structure of Temozolomide, the primary chemotheraputic agent against GBM 
Temozolomide is initially administered as a prodrug. In the liver, this drug is metabolized 
to its active form, diazomethane, through a mechanism initially proposed by Shealy et 
al.7 The diazomethane zwitterion then travels through the bloodstream to both the site of 
the tumor and other highly vascular sites within the body where it induces DNA 
methylation at either the O-6 or N-7 sites of the guanine base.8 In theory, DNA 
methylation should induce a cascade that prevents cellular replication and induces 
apoptosis; however, in practice, this is not the case. It has previously been determined 
that 55-65% of GBM patients possess overexpression of the DNA repair enzyme 
MGMT.9 MGMT overexpression effectively reverses any DNA methylation induced by 
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Temozolomide. In addition, diazomethane (the active form of Temozolomide) targets any 
rapidly dividing cell line, to include epithelial cells producing hair follicles, endothelial 
cells lining the lumen of the stomach, and hemocytoblast cells. The latter cells are located 
in the bone marrow and are responsible for differentiating into erythrocytes and 
leukocytes (a process known as hematopoiesis).10,11 Although some side effects are 
relatively inconvenient at their worst (hair loss, persistent nausea), myelodysplasia (or 
disruption of hematopoiesis) in particular can be detrimental to the patient’s long-term 
prognosis. Several studies have shown that iatrogenic myelodysplasia by treatments with 
Temozolomide results in lymphopenia, anemia, and acute hepatopathy.11 This in turn can 
lead to sepsis, tissue hypoxia, renal failure, and liver failure. Overall, disease progression 
is observed in nearly all patients treated solely with this chemotheraputic agent.3 
The second-line chemotheraputic option for GBM patients is Bevacizumab. 
Bevacizumab is a human monoclonal antibody (mAb) whose antigen is VEGF. As the 
mAb circulates throughout the blood, it binds to VEGF.12 This prevents the ligand from 
reaching its receptor (VEGF-R) which is overexpressed on the surface of the cancer cell. 
Overall, this causes anti-proliferative and anti-angiogenic effects. It is interesting to note 
that Bevacizumab performs the majority of its antitumoral effects outside the 
environment of the tumor bed itself, as its molecular weight prevents it from crossing the 
BBB. Again, when this treatment was placed into practice, it proved statistically 
ineffective at preventing tumor recurrence and growth as the cells in the tumor would 
begin to overexpress proteins such as hypoxia inducible factors (HIFs) that would 
promote subsequent angiogenesis.13,14 
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Immunotherapies are treatments that rely on the training of the body’s T-Cells to 
recognize, attack, and kill neoplastic cells. Though this has proved successful in other 
types of cancers, particularly in the blood cancer realm, GBM is unique in that it 
promotes global sequestration of the body’s T-cells to the point that GBM patients 
display lymphopenia mimicking that of AIDS patients.15 This process is further enhanced 
through any iatrogenic lymphopenia. Without white blood cells, immunotherapy is 
rendered ineffective. The final two options available in modern medicine to treat GBM, 
surgical resection and radiotherapy, fail mainly due to GBM’s ability to proliferate and 
migrate many millimeters away from the main tumor bed into seemingly healthy 
parenchymal tissue. As a result, neither surgeons nor radiation oncologists can guarantee 
100% removal of the neoplastic cells. After surgical resection and/or radiotherapy, the 
remaining neoplastic cells proliferate into new tumors, contributing to tumor recurrence 
and further treatment resistance.16,17 
In summary, no one sole treatment is completely effective in improving the long-
term prognosis of GBM. Though current treatments have a marginal effect on the 
eradication of the tumor core, little-to-no effect is seen at the invasive rim cells that 
migrate away from the main tumor mass. These untreated neoplastic cells then lead to 
tumor recurrence. This deadly cycle continues for 12-15 months until the patient 
succumbs to the physiological effects of neuronal necrosis and increased ICP. For the 
cancer to be completely eradicated, the invasive rim cells responsible must be specifically 
and irrevocably targeted and killed. 
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Superparamagnetic Iron Oxide Nanoparticles: Theory and Biomedical Applications 
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) have previously been 
explored as cytotoxic agents for the treatment of cancer.24-26 They do so by inducing 
thermal denaturation of biological macromolecules necessary for cellular survival and 
proliferation. This so called “cellular hyperthermia” occurs due to the nanoparticle 
exhibiting a unique magnetic property known as superparamagnetism. The property of 
superparamagnetism occurs at the nano-scale when an anisotropic magnetic dipole 
moment (µ) exists. 
To fully understand the magneto-thermodynamics of superparamagnetic material, 
it is imperative to understand the magnetic behavior of typical paramagnetic materials. 
The Brillouin function shows that paramagnetic magnetization (M) is dependent both on 
the external magnetic field (H) and the total angular momentum quantum number, J.18 J 
itself is described as the summation of the spin angular momentum (s) and the orbital 
angular momentum (l) vectors. Because a large number of electrons exist in 
nanoparticles, the value of 𝐽 approaches infinity.19 Thus, the Brillouin function simplifies 
to the Langevin function (L), which relates the susceptibility (𝜒 = $%) of a paramagnetic 
material to H:20 
                               𝐿(𝜉) = coth 𝜉 − 𝜉/0,                                      (1) 
where 𝜉 = 1%234 is proportional to the applied H, kB is Boltzmann’s constant, T is 
temperature, and 𝜇 is the magnetic dipole moment.20 The 𝜒(𝜉) graph shows that at high 
H values, cSPION becomes saturated. This observation is one of the pinnacle features that 
defines paramagnetic materials. 
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Figure 2: A graph depicting a generalized Langevin function. In the case of optimal paramagnets, M is 
plotted on the Y-axis as a function of H. 
 
The magnetization of a superparamagnetic material behaves identically to what is 
predicted by the Langevin paramagnetism.20 The key difference between these two 
materials, however, lies in the fact that the µnet of a superparamagnetic material is the 
summation of all electrons within that material. Thus, the massive amounts of electrons 
present in the nanoparticle results in extremely large magnetic moments relative to the 
constituent subatomic particles. This is the mathematical basis for distinguishing 
superparamagnetic materials from normal paramagnetic materials. 
 Another key difference that distinguishes superparamagnetic nanomaterials from 
atomic particles is the presence of uniaxial anisotropy. The magneto-thermodynamics of 
SPION growth dictate that, up to a specific size, it is energetically favorable for the µ of 
the SPION’s constituent atoms to align in a uniaxial manner (i.e. all atomic µs run in the 
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same direction).21 Above this critical size, however, the magneto-potential energy the 
material attains reaches a limit. To reduce the large amount of internal energy formed at 
large particle sizes, the µs fragment into two or more magnetic domains. When only one 
magnetic domain is present, the SPION can be described as uniaxially anisotropic. To 
switch the direction of the µ, an energy barrier, known as the anisotropic energy barrier, 
must be applied. The anisotropic energy barrier is dependent on both particle volume and 
identity. Its magnitude is given by 
                                                𝐸 = 𝐸7𝑉𝑠𝑖𝑛<𝜃,                                               (2) 
where V is particle volume, EB is the material’s anisotropy constant (4.6 kJ m-3 for 
maghemite), and q is the angle between the material’s easy axis (the native direction of 
µ) and magnetization direction.22 
 When H is applied to a SPION, magneto-potential energy is introduced to the 
system. The SPION reduces this incident energy in one of two ways. If the applied 
magneto-potential energy is above the anisotropic energy barrier, the particle undergoes 
Neel rotation, characterized by rotation of the magnetic moment itself. This rotation 
oscillates between the native direction of the SPION and the direction of the applied 
magnetic field with a frequency of 
                                                    𝜏? = 𝑓A𝑒CD3E3F ,                                                   (3) 
where f0 is the ferromagnetic resonance frequency in the demagnetization field (along the 
order of GHz).23 This is the energetically favorable method of reducing the magneto-
potential energy incident on the particle because the perturbance of the surrounding 
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solvent molecules is reduced by the physical material remaining immobile. Neel rotation, 
however, occurs only when the applied magneto-potential energy is greater than EB . A 
different type of rotation, known as Brownian rotation, occurs when the energy of the 
applied magnetic field is less than EB. With this rotation the SPION physically oscillates 
between its native direction and the direction of the applied magnetic field with a 
frequency of 
                                                     𝜏7 = GHIJKL234  ,                                                      (4) 
where h is the viscosity of liquid medium the nanoparticle is rotating in and rh is the 
hydrodynamic radius of the particle.21 When the nanoparticle physically rotates against a 
liquid media, thermal energy is produced due to the friction of the nanoparticle surface 
and the surrounding liquid molecules. Thus, for SPION-induced hyperthermia to be 
effective, a sufficiently low amount of magneto-potential energy must interact with the 
SPION such that Brownian rotation occurs. If the energy of H exceeds the anisotropic 
energy barrier, Neel rotation commences and the SPION gradually loses ability to 
physically rotate.21 
 In summary, the effective release of thermal energy by the SPION relies on two 
key factors. First, the frequency of Brownian rotation (and therefore the magnitude of 
heat produced) is dependent on the hydrodynamic radius of the particles as seen in 
equation 4. Second, the theory of magnetic domains states that above a critical radius (rc), 
the SPION loses its uniaxial anisotropic property as the single magnetic domain 
fragments into multiple domains. If this anisotropy is lost, the SPION has a µnet at or near 
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zero and thus cannot rotate when exposed to H. Thus, an optimal size exists that 
maximizes Brownian rotation but still retains its uniaxial anisotropy. 
SPION Ultralocalization: The TWEAK cytokine/Fn14 receptor axis 
Nanoparticles in general have shown to preferentially accumulate in the 
extracellular space surrounding tumors due to leaky and imperfect neovasculature (a 
property known as the enhanced permeability and retention, EPR, effect). As a result, 
preferential deposition in the extracellular matrix is achieved. This process is especially 
active at the liver, making SPIONs excellent candidates for detection of hepatic 
carcinomas. In this FDA-approved capacity, the particles induce inhomogeneities within 
the external magnetic field that are detectable via T1, T2, and T2* Magnetic Resonance 
Imaging.27 They, however, are not yet FDA approved for the treatment of the neoplastic 
cells. As previously mentioned, when exposed to magnetic fields attaining a particular 
magneto-potential energy, thermal energy is produced via Brownian rotation. As with 
any hyperthermia treatment, one of the largest problems with this form of therapy is that 
intracellular “hot spots” exist where the produced thermal energy destroys structures 
surrounding it but structures far away from the thermal energy release site remain 
unaffected.24 Due to poor control of where SPIONs localize in prior studies, little gross 
cytotoxic effect has been seen with prior intracellular hyperthermia experiments. 
Of the many enzymes and other proteins overexpressed in GBM, one in particular 
offers promise in promoting GBM-specific nanoparticle uptake. The Fn14 receptor is a 
102 amino acid type I transmembrane protein that acts as the receptor for a cytokine 
known as the TNF-like weak inducer of apoptosis (TWEAK).28 When TWEAK binds to 
Fn14, a signaling cascade begins. First, Fn14 trimerization occurs. This is shortly 
followed by TNFR-associated factor (TRAF) binding to the cytoplasmic tail of Fn14.29 
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The binding of TRAF to Fn14 activates numerous signaling cascades, most notably, the 
nuclear factor k-light-chain-enhancer of activated B-cells (NF-kB) pathway (Figure 3).30 
This pathway leads to the production of gene products that promote cellular survival, 
proliferation, and angiogenesis. Thus, it is intuitive that this pathway is one of the many 
intracellular signaling pathways that is upregulated in the pathogenesis of neoplastic 
cells.30 
 
Figure 3: A graphic showing the activation of Fn14 by TWEAK. Binding of the soluble TWEAK cytokine 
(sTWEAK) induced Fn14 trimerization, TRAF association, and activation of the NF-kB pathway. Image 
adapted from Winkles.30 
 
The overexpression of Fn14 is highly correlated with the invasiveness of the 
cancer subtype. Invasive rim cells tend to be the most aggressive and proliferative of 
GBM neoplastic cells, and, therefore, they have previously been found to exhibit 
constitutive NF-kB activation.31,32 Thus, it is logical that invasive rim cells have largely 
overexpressed Fn14 receptors compared to the normal parenchymal cells surrounding 
them. In fact, Fortin et al. showed via immunohistochemical detection that all invasive 
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rim cells analyzed in their study exhibited “moderate to strong” immunohistochemical 
detection of the Fn14 receptor protein.33 In contrast, a similar immunohistochemical 
assay for Fn14 on non-neoplastic glial cells showed that all cells showed weakly positive-
to-negative detection.34 From these data, it is clear that the Fn14 receptor can be used as a 
portal to selectively enter into neoplastic cells because only neoplastic cells significantly 
overexpress the protein in the environment of the central nervous system. 
 As discussed, the BBB remains one of the most significant challenges to the 
delivery of therapeutic agents to distant neoplastic cells in the central nervous system. 
The interface of the BBB with the vascular system lies within the capillary bed. At this 
level, three concentric layers of cells (endothelial cells, pericytes, and astrocytes) envelop 
the capillary bed).35 The concentric layer most proximal to the lumen of the capillary 
vessel consists of a layer of negatively charged phospholipid heads. Maghemite 
nanoparticles are known to have a negative surface charge (i.e. zeta potential: z); 
therefore, electrostatic repulsions would prevent them from interacting and therefore 
undergoing transcytosis through the BBB.36 To circumvent this, scientists have 
previously coated the surface of nanomaterials with lipophilic polymers such as 
poly(ethylene) glycol. Doing so effectively reduces the surface charge of the nano-
complex and allows transcytosis through the BBB.37 Thus, polymeric nanomaterials have 
been found to be the useful material for endovascular targeting of invasive rim cells. 
 TWEAK-modified nanotherapeutics have previously been shown to have high 
affinity and specificity towards targeting only cells displaying the Fn14 receptor (KD,(-) 
Fn14=1.62 nM versus KD, (+) Fn14=0.024 nM) both in vivo and in vitro.38 From this, it is 
logical that nanoconjugates decorated with the TWEAK protein will target and interact 
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with the exterior cellular membranes of neoplastic GBM cells. Uptake of any 
nanotherapeutic has largely been linked to both the size and shape of the therapeutic. He 
et al. shows that 15 nm gold nanoparticles (AuNPs) that endocytosed into GBM cells, 
escaped from the endosomal system, and deposited within mitochondria and nucleus 
(Figure 4).39 More importantly, He et al. showed that this endosomal escape occurred 
only when particles were along the order of 20 nm and attained a spherical morphology 
(4.a). Particles whose sizes were greater than 50 nm (4.b) and attained non-spherical 
morphologies (4.c) remained trapped within the endomembrane system and thus did not 
undergo endosomal escape. 
 
Figure 4: TEM micrographs (courtesy of He et al.) showing that the uptake of nanoparticles within the 
endomembrane system is largely dependent on both the size and geometric shape of the SPION, where 
particles that are approximately 15 nm could undergo endosomal escape (4.a) while those larger than 15 
(4.b) and with non-spherical morphologies (4.c) did not undergo endosomal escape. He et al. found that 
eventually, 15 nm spherical AuNPs accumulated in the mitochondria, nucleus, and lysosomes of GBM 
cells.39 
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This observation by He et al. is reproduced in a study by Liu et al., where 90 nm SPIONs 
were observed to preferentially deposit both within the intermembrane space of 
mitochondria (figure 5) and within the nucleus.40 It is through this preferential deposition 
into organelles via Fn14-mediatied nanoparticle internalization that we propose to 
ultralocalize the thermal energy produced from SPION Brownian rotation. This study sets 
the foundations for creating a novel treatment for GBM based on the thermal energy 
released by SPION rotation. In this study, we have successfully synthesized SPIONs via 
a straightforward and inexpensive electrochemical redox reaction. We demonstrate that 
size, and therefore magnetic properties, of a SPION can be precisely tailored by 
controlling the duration of iron oxidation. Following reaction optimization and 
bioconjugation of optimally sized nanoparticles, both fluorescence and transmission 
electron microscopy indicated that the GBM cells underwent programmed cell death 
within 3 hours of SPION nano-complex administration. Preliminary data also shows that 
SPIONs induce programmed cellular death only in cells that overexpress the Fn14 
receptor. These results indicate that the optimized nano-complex structures described 
here possess great promise in acting as targeted, cytotoxic agents towards aggressive 
GBM cells. 
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Figure 5: A. A schematic of the internalization of SPIONs (courtesy of He et al.) that proposes SPIONs 
coated with a stearic-polyethyleneimine polymer undergo endosomal escape following internalization. 
These SPIONs are proposed to travel to both the nucleus and mitochondria. This is seen via TEM in figure 
5B, where SPION internalization and subsequent mitochondrial deformation is shown by the orange 
arrows. The black arrows show healthy mitochondria.40 
A 
B 
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Materials and Methods 
Reagents 
• Lithium chloride (Fisher) 
• Solid iron (Fisher) 
• Phosphate buffered saline (PBS, pH=7.4, 0.1 M) (Fisher) 
• 2,2 dimethoxy-2-phenylacetophenone (DMPAP) (Fisher) 
• 4-dimethylaminopyridine (DMAP) (Fisher) 
• Succinic anhydride (Fisher) 
• 3-Mercaptopropyltrimethoxyamine (Fisher) 
• Trimethylamine (Fisher) 
• 2-(N-morpholino)ethanesulfonic acid (MES) (Fisher) 
• Lyophilized streptavidin (SAv) (Fisher) 
• 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (Fisher) 
• N-hydroxysulfosuccinimide (Sulfo-NHS) (Fisher) 
• Biotin-4-fluorescein (Fisher) 
• EZ-link micro sulfo-NHS-biotinylation kit (Fisher) 
• Annexin V/Propidium Iodide fluorescence apoptosis kit (Fisher)  
• Glutaraldehyde (Fisher) 
• Paraformaldehyde (Fisher) 
• Sodium Cacodylate (Fisher) 
• Osmium Tetraoxide (Fisher) 
• Fetal Bovine Serum (Fisher) 
• Gentamycin (Fisher) 
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• Poly(l)-lysine (Fisher) 
• HEPES Buffer (Fisher) 
• Cell Apoptosis Kit (Invitrogen) 
• Allyl PEG10-OH (PolySciences) 
• TWEAK cytokine (R&D systems)  
• U87 Glioblastoma Multiforme (ATCC).  
• Dulbecco’s Modified Eagle Media (DMEM) (Millipore Sigma) 
• LX-112 Epoxy Substitute Resin (EMS) 
• Uranyl Acetate (EMS) 
• Size 3 BEEM Capsules (EMS) 
• Jurkat T-Lymphocytes (Courtesy of Dr. Randall Reif) 
• Penicillin (Courtesy of Dr. Randall Reif) 
• RPMI 1740 (Courtesy of Dr. Randall Reif) 
• Doxycycline (Courtesy of Dr. Lynn Lewis) 
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General Experimental 
The SPIONs were synthesized with a CH 600C series potentionstat. The SPIONs 
were analyzed using a Morgani FP 5005 transmission electron microscope (TEM), Perkin 
Elmer Spectrum RX-1 infrared spectrometer with Pike MIRacle ATR attachment, and 
LakeShore 7410 Vibrating Sample Magnetometer (VSM). The synthesized polymer was 
analyzed via IR spectrometry and 1HNMR Spectroscopy with an Oxford 300 MHz NMR. 
Progression of TWEAK crosslinking was monitored using a Horiba Jobin Yvon 
fluorimeter. Throughout cell death assays, GBM cells and SPIONs were exposed to a 
constant low energy (21 mT) magnetic field created by an air-core solenoid. Cell death 
was monitored utilizing a Nikon Eclipse Ts2R-FL epifluorescence microscope and the 
previously mentioned TEM.  
SPION Synthesis and Characterization  
The oxidative method of producing SPIONs was initially reported by Starowicz et 
al.41 It was employed here and optimized with various modifications. Most notably, the 
duration of synthesis was varied from 15 minutes to 60 minutes in place of varying 
[H2O]. To create an adequate aqueous environment for nanoparticle synthesis, a beaker 
containing 200 mL of 0.100 M aqueous LiCl was sparged with Ar(g) for a period of 10 
minutes prior to introduction of the electrodes. The gas was continually bubbled through 
the solution throughout the duration of the synthesis. Ag/AgCl acted as the reference 
electrode, Pt as the counter electrode, and Fe(s) as the working electrode. The complete 
experimental setup is seen in figure 6.  
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Figure 6: The experimental setup for SPION synthesis, where Ar(g) was bubbled into a solution of 0.100 M 
aqueous LiCl at RT. Fe(s) acted as the working electrode, Pt(s) as the counter-electrode, and Ag/AgCl as 
the reference electrode. 
 
The reaction was run at a potential of 0.400 V and the duration of iron oxidation 
was manipulated to produce SPIONs of varying diameters. SPIONs were collected, 
centrifuged at room temperature (RT, 4000 rpm) and re-suspended in PBS. All samples 
were analyzed via TEM, Attenuated Total Reflectance Fourier-Transform Infrared 
Spectroscopy (ATR-FTIR), and VSM. Thermal energy output secondary to H-application 
was measured with Hstatic=21 mT in an air-core solenoid connected to a DC generator. 
The magnetic field was created by flowing 0.46 A of current through a 10cm long air-
core solenoid attaining 360 turns of copper wire. The change in temperature of the 
aqueous SPION mixture with respect to time, (𝜕𝑇/𝜕𝑡)𝑃,𝑉,𝑛 , was monitored by placing a 
digital thermometer into an aqueous suspension of SPIONs contained in a 3 mL glass 
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container and applying the static magnetic field over a period of 10 minutes. Values were 
normalized with respect to the mass of SPIONs in the suspension. (𝜕𝑇/𝜕𝑡)𝑃,𝑉,𝑛 of the pure 
solvent was subtracted from the attained values.  
Synthesis of Siloxane-Terminated PEG Molecule 
The polymer synthesis procedure was derived from Bloemen et al. and used with 
only minor modifications.42 Briefly, 1.990 g (4.0 mmol) of neat allyl-PEG10-OH (figure 
14, molecule 1) was combined by stirring with 440 mg succinic anhydride and 9.7 mg 
DMAP for 16 hours at 50°C in a round bottom flask. The resultant product (figure 14, 
molecule 2) was precipitated with cold diethyl ether and vacuum filtered to remove any 
solid impurities and isolate the filtrate (molecule 2). Then, 1 mmol of molecule 2 was 
combined by stirring with 186 µL of (3-mercaptopropyl)-trimethoxysilane and 12.8 mg 
of DMPAP for 1 hour under 365 nm light at room temperature (RT), forming molecule 3 
(see figure 14). The disappearance of the C=C p bond during this reaction was was 
monitored via thin film IR spectroscopy on NaCl plates. 
SPION Functionalization 
To conjugate the synthesized polymer to the SPION, 3 mmol of molecule 3 was 
added to a beaker consisting of 100 mg SPIONs, 50 mL toluene, 2.5 mL triethylamine, 
and 50 mL of water. The mixture was ultrasonicated for 5 hours at RT. The PEGylated 
nanoparticles were precipitated by adding 50 mL of heptane and copious washing with 
acetone. The PEGylated particles were then dried in a vacuum oven overnight, massed, 
and resuspended in Nanopure water to achieve a final concentration of 50 mg/mL.   
Addition and Evaluation of Streptavidin (SAv) 
The conjugation of a GBM-targeting molecule (a cytokine known as TWEAK) 
took place in two steps. The first involved the conjugation of streptavidin (SAv) to the 
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SPION-COOH complex. To do this, 800 µL of the PEGylated SPIONs (50 mg/mL) was 
re-suspended in MES buffer (0.05 M, pH=5) and combined with 32 µL of 150 mM EDC 
(in MES Buffer) and 16 µL of 300 mM Sulfo-NHS (in MES buffer) for one hour at RT. 
The SPIONs were isolated by centrifugation, re-suspended in 800 µL PBS, and combined 
with 80 µL of 10 µg/µL SAv overnight. The final product was re-suspended in 800 µL 
PBS and stored at -20°C.  
Fluorescence spectroscopy was performed to confirm the presence of SAv on the 
surface of the SPION using a biotin-4-fluorescein probe by combining 0.25 µL of 160 
µM biotin-4-fluorescein to 3 mL SPION-SAv nanoparticles (50 mg/mL). Fluorescence 
quenching was assessed with a Horiba Jobin Yvon fluorimeter with lex/lem at 485 
nm/525 nm, respectively. 
Addition and Evaluation of TWEAK 
The TWEAK ligand was biotinylated according to the protocol from the 
biotinylation kit. Briefly, 110 µL of biotin (50 mM in Nanopure water) was added to 1 
mL of a TWEAK cytokine solution (1 mg/mL in Nanopure water) to achieve a 20-fold 
biotin:TWEAK ratio. The mixture reacted for 60 minutes at RT. A spin desalting column 
was prepared and the newly biotinylated protein sample was spun through the column via 
centrifugation at 1000g for 2 minutes at RT. The biotinylayted TWEAK was added to the 
SPION-SAv complex by combining 0.25 µL of biotinylated TWEAK and 100 µL of the 
SPION-SAv suspension for 1 hour at RT. The presence of TWEAK on the SPION-SAv 
complex was determined via fluorescence spectroscopy using the same fluorescent probe 
and lex/lem described above.  
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Cell Culture Conditions  
Human U87 Glioblastoma Multiforme cells known to express the Fn14 receptor38 
were maintained in DMEM supplemented with 10% fetal bovine serum (FBS) and a 
1:2000 ratio of Gentamycin:DMEM. The GBM cells were grown on 75 cm2 plates at 
37°C and 5% CO2. Sterile media changes were performed every 3 days until the cells 
were ~80% confluent, then sub-cultured at a 1:5 ratio to maintain a stock cell line. Jurkat 
T-Lymphocytes, graciously donated by Dr. Randall Reif, were maintained in RPMI 1740 
media supplemented with 10% FBS and 1% penicillin antibiotic. 
Fluoromicroscopic Detection of SPION-Induced Apoptosis  
The GBM cells were sub-cultured onto poly-L-lysine doped sterile glass slides. A 
sterile size 3 BEEM capsule was added with non-cytotoxic glue (3:1 w/w mixture of 
paraffin: Vaseline) to the glass cover slip, as seen in figure 7. 
 
Figure 7: A diagram of the coverslip/BEEM capsule setup. Briefly, BEEM capsules were inverted 
and added with non-cytotoxic glue to a poly-L-lysine-doped cover slip, acting as a physical barrier that 
isolates a select few number of cells. These cells are what were analyzed. 
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20 µL of SPION nano-complexes (5 mg/mL) was added to different aliquots of cells 
within the BEEM capsule for periods of 20 minutes, up to 4 hours. In all cases, the 
SPIONs and cells were placed in a 21 mT magnetic field. The magnetic field was created 
as previously described using the air-core solenoid. The cells were suspended within the 
air core solenoid and exposed to the magnetic field for their respective durations of time. 
Incubation of the GBM cells with doxorubicin/sterile PBS in the absence of any magnetic 
field acted as the positive/negative controls, respectively. Glass slides were washed, first 
with cold PBS, then Annexin V binding buffer (50 mM HEPES, 700 mM NaCl, 12.5 mM 
CaCl2, pH=7.4). Following this, 4 µL of a 50 µg/mL solution of propidium iodide and 20 
µL of an Annexin V suspension was added to the cells for 15 minutes. Excess 
fluorophore was removed by additional washing in Annexin V buffer, and the cells were 
assessed for apoptosis and cell death via epifluoresence microscopy. SPION-TWEAK 
complexes were also tested against Jurkat T-lymphocytes by incubating 20 µL of SPION-
TWEAK complexes (5 mg/mL) with the cells for 3 hours in the presence of the magnetic 
field. Fluorescence staining and microscopy took place as previously described. 
Evaluation the Ultramorphological Changes of SPION-Induced Apoptosis via TEM  
 GBM cells were subcultured into small petri dishes. In a manner identical to the 
fluoromicroscopic assays, 20 µL of SPION nano-complexes (5 mg/mL) was added to 
different aliquots of cells for periods of 20 minutes, up to 4 hours in the low energy 
magnetic field (created as previously described). In all cases, the SPIONs and cells were 
placed in a constant 21 mT magnetic field using the air core solenoid as previously 
described. SPION internalization was halted by incubating the cells with a fixative 
consisting of 2.5 % v/v glutaraldehyde and 1% v/v paraformaldehyde in 0.12M sodium 
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cacodylate buffer (SCB) at pH=7.4 for 40 minutes at RT then overnight in the 
refrigerator. The next day, the cells were washed with SCB and stained with 1% OsO4 
(in H2O) for 60 minutes. The OsO4 solution was decanted and the cells were again 
washed with SCB and incubated overnight with 1% uranyl acetate (in H2O) in the 
refrigerator. Following overnight staining with uranyl acetate, the cells were washed with 
cold water and dehydrated by rinsing with ethanol solutions of ascending concentrations 
(from 30% to 100%). The cells were then embedded in LX112 epoxy substitute resin. 
Modified BEEM capsules were added over the cells and filled with additional resin. The 
entire sample was placed in a 60°C oven and allowed to harden for 48 hours. Following 
this, BEEM capsules were harvested (with pliers) and sent to the George Washington 
University (GWU) Nanofabrication and Imaging center for thin-film slicing onto TEM 
grids with an ultramicrotome. Samples were sent back to the University of Mary 
Washington and analyzed under TEM. 
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Results and Discussion 
SPION Synthesis and Characterization 
In this study a precise and direct correlation between duration of iron oxidation 
and the SPION diameter was made. To our knowledge, this is the first time this 
correlation has been empirically determined, providing a relatively facile and new 
method of controlling SPION size. Measurements from vibrating sample magnetometry 
and thermogenic analysis empirically showed that there is an optimal nanoparticle size 
that releases maximal amounts of thermal energy when exposed to an external magnetic 
field. These optimized SPIONs were bio-conjugated with a cancer targeting molecule and 
show promise in inducing programmed cell death in a time-dependent manner.  
Electrolytic synthesis of iron oxide nanoparticles initially produced a light-yellow 
solution that darkened and eventually turned a murky green color with particulates 
floating throughout the solution. The proposed iron oxidation reactions occur sequentially 
as follows:  
(I): Fe(s)+2OH- (aq)à Fe(OH)2(s)+2e- 
(II): 3Fe(OH)2 (s)àFe3O4 (s)+ 2H2O (l)+ H2(g) 
(III): 2Fe3O4 (s) +2OH- (aq) à3g-Fe2O3 (s)+H2O (l)+2e- 
The reaction begins with the oxidation of Fe(s) by an aqueous hydroxide species present 
in solution, forming iron (II) hydroxide (a green-blue species). The formation of the 
Fe(OH)2 accounts for the noted color changes in solution. Its formation is also supported 
by evidence previously gathered from Starowicz et al.41 In an anaerobic and aqueous 
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environment, Fe(OH)2 a redox reaction via the Schikorr reaction (step II) to magnetite. 
The continued oxidation of magnetite strips electrons from the crystal structure and 
converts Fe2+ to Fe3+. The resultant electron holes induce defects in the crystal’s inverse 
spinel structure. This, in combination with all Fe atoms being in the 3+ oxidation state, 
results in the formation of maghemite (reaction III). The lack of Fe2+ and presence of 
electron holes leads to changes in the geometry of the nanoparticle’s crystal structure, 
best described by Wu et al.43 Magnetite attains a face centered cubic spinel structure 
where Fe2+ ions occupy half of the octahedral sites and the Fe3+ ions are split among the 
other half of the octahedral sites and all tetrahedral sites.43 In maghemite, however, Fe3+ 
ions fill all tetrahedral sites and most octahedral sites, with the octahedral sites being 
filled with the electron holes. 
The slight variance in structure between magnetite and maghemite has fairly 
significant biological consequences regarding stability and cytotoxicity. In any living 
system, Fe2+ can be oxidized to Fe3+ by H2O2 innately present in the cell (as a byproduct 
of mitochondrial oxidative phosphorylation), given as 
(IV): Fe2+ + H2O2 àFe3+ + HO● + OH- 
This reaction, known as the Fenton reaction, produces harmful hydroxyl radicals that can 
result in unwanted and nonspecific cytotoxicity, potentially harming healthy tissue. 
Unwanted Fenton reactions can be circumvented by minimizing the presence Fe2+ species 
in the nanoparticle structure. The utilization of this electrochemical method of synthesis 
best ensured this by continued application of an oxidative potential for 20 minutes. 
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Magnetite and maghemite appear identical in both VSM and TEM studies. To 
differentiate amongst the slight variances in crystal structure between the two materials, 
ATR-IR spectroscopy was utilized. Briefly, IR spectroscopy operates by introducing 
electromagnetic radiation (EMR) to a sample. This EMR induces different patterns of 
bond vibrations that can be utilized to, in this case, differentiate between maghemite and 
magnetite. It was originally reported by Tartaj et al. that bond vibration patterns in the 
1000 cm-1 to 200 cm-1 range is the best for discriminating between maghemite and 
magnetite as these IR energies have been shown to be sensitive to the order-disorder 
characteristics of magnetic nanoparticles.44 The magnetite structure (which is more 
ordered than maghemite) produces two large signals at 570 cm-1 and 360 cm-1, while 
maghemite produces numerous vibrational peaks within the same region of interest. This 
increase in the number of absorption signals is associated with increase in the disorder of 
the material.45 ATR-FTIR spectroscopy gathered on the nanoparticles synthesized in this 
work is shown in figure 8. 
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Figure 8: IR spectroscopy of the nanoparticles synthesized in this work. The peak at 680cm-1 along with the 
numerous other vibration signals indicate that a disordered maghemite crystalline structure is present in the 
nanoparticles. 
 
The presence of numerous vibration signals within this IR range, along with a broad 
vibrational peak at 680 cm-1 (arising from Fe-O vibrations), all indicate that the 
synthesized nanoparticles retain a disordered crystalline structure. By definition, 
maghemite is considered to have a more disordered structure due to the presence of the 
electron holes induced within the octahedral sites of the crystal. Thus, by evidence of IR 
spectroscopy, it is asserted that the nanoparticles produced in this work retain a 
crystalline structure similar to maghemite.  
 As previously stated, maghemite displays superparamagnetic properties at the 
nanoscale. These properties largely depend on both the geometric size and number of 
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magnetic domains within the material. Thus, it was quickly realized that precisely control 
of SPIONs size was vital to this work. This was achieved by controlling the duration of 
synthesis of the electrochemical reaction. Diameters of SPIONs synthesized for differing 
durations of time were measured via TEM and plotted as a function of their respective 
duration of synthesis. Figure 9 shows the physical morphology of the SPIONs from TEM 
and the correlation between SPION size and duration of electrochemical synthesis. 
From figure 9, it is clear that the SPIONs attain an electron-dense, spherical morphology. 
This is consistent with what was reported by Starowicz et al.41 The resultant SPION 
measurements were plotted as a function of the duration of electrochemical oxidation. 
When this was done, a linear trendline is achieved with a correlation coefficient of 0.97. 
Compared against the original literature, this correlation coefficient is greatly improved 
from what was originally reported by Starowicz et al. (see Starowicz figure 9).41 The 
reproducibility of this synthetic method was tested over twenty times by six different 
undergraduate researchers across multiple years, all with no significant deviance from the 
reported trendline. Thus, we can assert with high confidence that this method shows 
improved linearity and reproducibility compared to the original method initially reported 
by Starowicz et al. 
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Figure 9: (top) TEM images of a sample of SPIONs synthesized in this work. From TEM, these SPIONs 
appear as spherical, electron dense structures. (bottom) SPION size measurements were plotted as a 
function of the duration of synthesis (in minutes). From this relationship a correlation coefficient of 0.97 is 
achieved. This indicates that, with great precision, the size of the SPION can be controlled simply by 
varying the duration of the electrochemical oxidation reaction. 
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Just as important as average diameter of a SPION is the variance of individual 
SPION diameters from their respective means. As SPION size is largely correlated to 
magnetic properties, thermal energy output, and cellular internalization, having small 
variances from the mean SPIONs size is essential to both producing reliable thermal 
energy output and efficient cellular internalization. Here, SPION size variance is studied 
by employing the coefficient of variation (CoV), which normalized the standard deviation 
of a samples against the mean sample size, as seen in equation 5: 
𝐶𝑜𝑉 = ST(UCU)VWTUW = XY  , (5) 
where x is the individual value,  𝑥 is the mean of a data set, n is the number of samples in 
that data set, and s is the calculated sample standard deviation. The percent frequency of 
each set of CoV values was then calculated and is displayed in figure 10. 
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Figure 10: The percent frequency of a range of coefficients of variation (CoV=s/𝜇) gathered from all 
SPION diameters measured. From this data set, it is shown that most SPIONs attained a CoV of less than 
0.04 units. This indicates a small spread of data points amongst their respective means. 
 
Figure 10 shows that most of the SPIONs attained a CoV value less than or equal to 0.04 
units with no SPIONs analyzed having CoV values greater than 0.4 units. This indicates 
that the SPIONs analyzed achieved a very small spread from their respective means. 
Overall, this provides evidence that by varying the duration of electrochemical oxidation, 
it was not only possible to achieve precise average SPION sizes, but that the spread of 
data among each size category remained small. Thus, the synthetic method has not only 
proved to be reliable but also precise and accurately reproducible. 
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Following analysis of SPION size, the magnetic properties of the synthesized 
nanomaterials were analyzed utilizing vibrating sample magnetometry (VSM). In brief, 
VSM operates by mechanically vibrating a sample placed in a static magnetic field with a 
piezoelectric actuator. Based on Faraday’s law, movement of a magnetic material in a 
static magnetic field produces an electrical field. This electrical field is detected by the 
instrument by another electromagnetic coil, amplified, and shown on a computer. By 
varying the external magnetic field (H), the magnetization (M) also changes and a 
hysteresis loop (i.e. M(H) curve) is generated.46 Within the hysteresis loop, two values 
are of importance to this study. Saturation magnetization (Msat) is defined as when the 
magnetization of the magnetic material can no longer be increased despite increases in 
the external magnetic field. A lower Msat value indicates that a smaller magnitude of H is 
needed to achieve maximal magnetization. Theoretically, superparamagnetic materials 
would have low Msat values as uni-magnetic materials would require low amounts of 
magneto-potential energy to achieve saturation. Coercivity (Hc) is defined as the points at 
which the M(H) curve crosses the x-axis. Its value describes the amount of magnetization 
leftover within the material after the external magnetic field has been completely 
removed. Ideal superparamagnetic materials have Hc values of 0; however, 
experimentally, superparamagnetism has previously been defined as Hc<0.01T.47  Figure 
11 shows the M(H) curves of the SPIONs synthesized in this work. 
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Figure 11: M(H) curves of the SPIONs synthesized in this work taken via vibrating sample magnetometry. 
From this graph it is seen that 53 nm SPIONs attain the largest saturation magnetization while 21 nm 
SPIONs attain the smallest. 
 
All SPIONs analyzed via VSM display sigmoidal curves. This indicates that all materials 
analyzed do not display diamagnetic or paramagnetic behavior, as both the former and 
latter attain linear trendlines in hysteresis loops. They are all either 
ferromagnetic/ferrimagnetic, or superparamagnetic. Figure 11 best displays the Msat 
behavior of the SPIONs with 53 nm particles attaining the largest Msat value (53 emu/g) 
and 21 nm particles attaining the smallest (8.9 emu/g). This observation provides the first 
evidence that 21 nm SPIONs have optimal superparamagnetic behavior as they require 
the least amount of incident magnetopotential energy to achieve saturated magnetization. 
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Figure 12 magnifies the origin of the graph in figure 11 to analyze the coercivity of the 
SPIONs. 
 
Figure 12: A magnified view of the hysteresis loops presented in figure 9. From this view it is clear that 21 
nm SPIONs display the greatest amount of superparamagnetic behavior. Additionally, by the working 
definition of superparamagnetism, 45 nm and 53 nm SPIONs are above the quantitative threshold (100 
Oe=0.01T) of what is considered to be superparamagnetic.  
 
Figure 12 shows two main important observations. As previously stated, the closer the 
M(H) curve approaches 0 on the x-axis, the more superparamagnetic the material is. By 
this definition, 21 nm SPIONs retain the most superparamagnetic behavior. This aligns 
with the observations gathered from figure 11 regarding the Msat values as the magnetic 
dipoles of all atoms in superparamagnetic materials point in a single direction and 
therefore require low amounts of magnetopotential energy to align in the direction of H. 
Secondly, both 45 nm and 53 nm particles surpass the quantitative threshold for what is 
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considered to be superparamagnetic. The sizes of these materials have become so large 
that fractured domains appear in the crystal, and thus, larger amounts of magnetopotential 
energy are required to achieve saturation. This is seen in figure 11 as both 45 nm and 53 
nm particles require larger amounts of energy to achieve Msat. To this point, a correlation 
has been made between SPION size and magnetic properties that supports what was 
initially theorized regarding ideal size-dependent superparamagnetism and the effects of 
magnetic domains diminishing those optimal properties. From here, a second correlation 
needs to be performed, linking optimal superparamagnetism to thermal energy output. 
 Thermal energy production was measured by suspending SPIONs in DI H2O and 
placing the mixture in a low-energy magnetic field (B=21 mT). The change in 
temperature (DT) of the solution was measured over the course of 10 minutes for all sizes 
of SPIONs. DT of pure solvent was background subtracted from all values and the 
resultant temperature gradients are shown in figure 13: 
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 Figure 13: The change in temperature of a SPION solution over the course of 10 minutes in the presence of 
a low-energy magnetic field. From these data it can be seen that 21 nm SPIONs were able to induce the 
greatest DT over the course of 10 minutes. 
  
Figure 13 shows that all SPIONs were able to induce changes in temperature of the 
aqueous solution. The derivative of the temperature gradients was taken with respect to 
time at constant pressure, volume, and moles of SPION. Presumably this temperature 
change was induced by the incomplete oscillatory rotations of the SPIONs in the mixture.  
SPION Size (nm) [𝝏𝑻𝝏𝒕_𝑷,𝑽,𝒏(°C s-1g-1) 
19 0.053 
21 0.058 
45 0.051 
53 0.052 
Table 1: A tabulation of the change in temperature as a function of time at constant pressure, volume, and 
temperature. From these data, it is seen that 21 nm SPIONs produce the greatest change in temperature per 
unit time. 
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The results of this analysis are tabulated in table 1. Figure 13 shows that 21 nm SPIONs 
were able to induce the greatest [𝝏𝑻𝝏𝒕_𝑷,𝑽,𝒏over the experimental course, followed by 19 nm, 
45 nm, and 53 nm SPIONs (quantitatively supported by the tabulated data in table 1). 
Interestingly, this closely follows the degree to which each of the respective SPIONs 
display superparamagnetic behavior, with 21 nm SPIONs displaying the greatest and 53 
nm SPIONs the least. In addition, the superparamagnetic SPIONs (19 nm, 21 nm) both 
induced larger [𝝏𝑻𝝏𝒕_𝑷,𝑽,𝒏 values than the non-superparamagnetic particles (45 nm, 53 nm). 
Taken together, figure 13 and table 1 quantitatively show that the property of 
superparamagnetism is directly correlated to thermal energy output. Because 
superparamagnetism itself is correlated with particle size, thermal energy output is linked 
to SPION size and by manipulating the latter, the former can be controlled. It is through 
harnessing this thermal energy that thermal denaturation of vital intracellular structures 
that leads to Glioblastoma Multiforme cell death will be achieved. 
SPION Biofunctionalization 
 It is well known that bare SPIONs lead to aggregation and activation of an 
immune response in in vivo and in vitro systems.42 To circumvent this, a poly(ethylene) 
glycol (PEG)-based polymer was added to the surface of the SPION. In addition to 
“cloaking” the SPION from the immune system, this polymer also contained a carboxylic 
acid functional group that was used in future steps to add the GBM-specific TWEAK 
cytokine. The reaction progressed as detailed in figure 14 and was monitored via IR 
spectroscopy. The IR spectra of the allyl-PEG10-COOH (molecule 2) contained a 
fingerprint region independently unique when compared to IR spectra of the starting 
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reagents (succinic anhydride and molecule 1) (data not shown). A carbonyl signal 
representing the formation of a C=O p-bond is present at 1730 cm-1. This is highlighted 
by a blue box in figure 14. Following addition of the siloxane group via a click reaction 
under UV light, IR spectroscopy confirmed the loss of the C=C p bond at 1650 cm-1 
while retaining the C=O p bond previously mentioned. All spectra obtained agree with 
those originally reported by Bloemen et al.42 Although IR spectroscopy is facile and 
easily accessible, it was admittedly difficult to visualize the transformation between 
molecules 2 and 3, particularly the disappearance of the C=C p bond with solely IR 
spectroscopy. To ensure molecule 3 was synthesized, 1HNMR spectroscopy was 
performed and the obtained spectra are seen in figure 15. 
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Figure 14: Infrared spectra of the allyl-PEG10-OH polymer (molecule 1), the carboxy-terminated PEG 
molecule (molecule 2) and siloxane-terminated PEG molecule (molecule 3). Between molecules 1 and 2, 
the emergence of a signal at 1730 cm-1 indicates the presence of a C=O group (highlighted by the blue 
box).  Between structures 2 and 3, the disappearance of the signal at 1650 cm-1 indicates the loss of a C=C p 
bond (highlighted by the red arrows). 
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Figure 15:1HNMR spectra of the molecules 2 and 3. Of particular importance are the loss of peaks at d=6.0 
ppm and d=5.25 ppm (highlighted by the red box). These signals are representative of hydrogens abutting 
the C=C p bond and loss of these signals provides significant evidence that the C=C p bond was lost. 
Thioester-specific peaks also emerge at d=2.25 and d=2.5 ppm, respectively in the 1HNMR of molecule 3.  
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The 1HNMR spectra between molecules 2 and 3 display both common and unique 
chemical shifts. For example, the large peaks at d=2.25 ppm and d=3.75 ppm account for 
the hydrogens in the repeating polymer subunit of the molecule. These peaks are retained 
between molecules 2 and 3. Of particular significance is the disappearance of signals at 
d=6.0 ppm and d=5.25 ppm. Chemical shifts in this range are traditionally indicative of 
vinylic hydrogens; therefore, loss of signals within this range provides strong evidence 
that the C=C p bond was lost and replaced with the S-C bond upon the addition of the 3-
mercaptopropyltrimethoxyamine group in molecule 3. Thioester-specific peaks at d=2.25 
and d=2.5 also support the claim that the click-chemistry reaction occurred as described. 
This particular pattern of signal gains and losses is supported by the literature values 
originally gathered by Bloemen et al.42 
Sonication of the polymer, SPION colloid mixture, and a small amount of water 
induced the formation and collapse of microscopic vapor bubbles. Upon collapse of the 
vapor bubble, a large amount of energy is released to that local micro-environment. The 
theory is that this energy lowers the activation energy barrier that allows for covalent 
bonding of the polymer to the nanoparticle through the formation and interaction of 
sonolysis radicals. This mechanism was not further explored or empirically proven within 
the scope of this research. Following attachment of molecule 3 to the surface of the 
SPION via ultrasonication, the carboxylic acid terminus of the polymer was modified by 
EDC/Sulfo-NHS chemistry to create a suitable platform to first attach a SAv protein and 
then attach the cancer targeting molecule. Carbodiimide (EDC) molecules are favorable 
for crosslinking carboxylic acids because no portion of their structure becomes part of the 
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final bond between the two conjugated molecules. The carbon involved in the 
carbodiimide functional group is electrophilic and is a prime candidate for nucleophilic 
attack by the carboxylic acid alcohol. This forms an unstable o-acylisourea intermediate. 
To stabilize the intermediate for further reaction, N-hydroxysuccinimide is added via an 
additional nucleophilic reaction, with the alcohol on the latter species attaching the 
electrophilic carbonyl carbon on the o-acylisourea intermediate. A final nucleophilic 
attack by a primary amine on a protein of interest (either SAv or TWEAK) produces the 
final stable conjugate with two target molecules linked by an amide linkage. This 
crosslinking mechanism is depicted in figure 16.  
The presence of SAv was confirmed with a fluorescence quenching assay. Biotin-
4-fluorescein is a fluorophore that emits light at 520 nm. When bound to SAv, however, 
the fluorophore’s ability to emit light is quenched. This property can be utilized to assess 
for the presence of SAv. Following SPION-SAv isolation, biotin-4-fluorescein was added 
and was assessed for quenching. This was repeated using PBS, SPION-PEG, and SPION 
(see figure 17). When the fluorophore binds to pure SAv, the fluorescent emission largely 
decreases, as expected. When the fluorophore was mixed with both uncoated SPIONs and 
SPION-PEG complexes, mild quenching occurred, though not to the extent as when the 
fluorophore is bound to SAv. This could be attributed to either a decrease in the amount 
of light reaching the fluorophore (likely through absorption of the light by the SPIONs) 
or nonspecific binding of the fluorophore to the SPION or polymer. When the 
fluorophore was mixed with the SPION-SAv complex, however, a decrease in emission 
was observed consistent with the fluorophore+SAv test. These results indicate the 
presence of SAv on the surface of the SPION. 
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Figure 16: The simplified mechanism by which EDC/Sulfo-NHS operates. Briefly, the hydroxyl on a 
COOH functional group performs a nucleophilic attack on a carbodiimide group, forming an unstable o-
acylisurea group. This reacts with sulfo-NH which bonds to the carbonyl carbon through a nucleophilic 
attack. The primary amine of a protein then attacks the same electrophilic carbonyl, and the sulfo-NHS 
group leaves as a nitroso compound. The final product is two target molecules linked through an amide 
bond. 
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Figure 17: Fluorescence spectroscopy assay of the SPION-SAv complexes with pure fluorophore (negative 
control), fluorophore with SAv (positive control), uncoated SPION, SPION-PEG, and SPION-SAv. The 
fluorophore exhibits large amounts of quenching when incubated with SPION-SAv in a manner similar to 
when incubated with pure SAv. 
 
The purpose of the SAv was to utilize its strong affinity towards biotin to create a 
strong linker system that can connect the SPION to a biotinylated cancer targeting 
molecule. In this study, the targeting molecule used was the TNF-related weak inducer of 
apoptosis, or TWEAK, cytokine. Cytokines, like all proteins, possess numerous primary 
amines available for modification. These amine groups were manipulated with a Sulfo-
NHS-Biotin linker available through the EZ-Link Sulfo-NHS kit, the mechanism of 
which is shown in figure 18. 
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Figure 18: The biotinylation mechanism of the TWEAK cytokine. Briefly, a primary amine attacks the 
carbonyl abutting the sulfo-NHS group. This causes Sulfo-NHS to act as a leaving group with the nitroso 
group eventually resolving to a tertiary amine with an alcohol group. The long alkyl chain linking the 
TWEAK to the biotin ensures there is adequate space between the biotin and the protein such that no steric 
hindrance would occur in the SAv-Biotin binding reactions. 
 
In this mechanism, a nonspecific primary amine undergoes nucleophilic attack of the 
carbonyl carbon directly abutting the sulfo-NHS group. This induces Sulfo-NHS to leave 
as a leaving group with its nitroso group resolving to a tertiary amine following hydration 
with water. What is left on the TWEAK is a long alkyl chain connecting the protein to the 
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biotin molecule. The alkyl chain minimizes any steric hindrance the TWEAK protein 
would induce in the SAv-Biotin linking reaction. 
The binding of biotin to SAv is one of the strongest noncovalent interactions in 
nature, thus, by introducing the biotinylated TWEAK molecule to the SPION-SAv group 
at RT under gentle shaking, the SAv-biotin noncovalent interaction was formed. 
Following isolation and resuspension of the SPION-TWEAK complexes, fluorescence 
spectroscopy was again utilized to confirm the presence of TWEAK on the SPION core 
with the same fluorophore. It was hypothesized that because all binding sites on the 
SPION-SAv complex were now occupied with biotinylated TWEAK, no significant 
fluorescent quenching would occur to the extent of what is seen in figure 17 as the 
fluorescence biotin would have few-to-none open binding sites to associate with. Figure 
19 shows that negligible quenching occurred when the fluorophore was incubated with 
SPION-TWEAK complexes, confirming the original prediction. 
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Figure 19: Fluorescence spectroscopy of SPION-TWEAK complexes with a biotinylated fluorophore 
shows negligible quenching, indicating that the SAv sites on the SPION-SAv core are occupied with 
biotinylated TWEAK molecules. 
 
The magnetic behavior, diameter, and thermogenic properties of the fully 
bioconjugated SPIONs were again characterized. TEM analysis of the SPIONs showed 
that the bioconjugated SPION complex grew, on average, by 33 nm +/- 6 nm to a final 
average size of 52 nm +/- 6 nm, as seen in figure 20. 
 
Figure 20: A TEM image of the final bioconjugated SPION product, showing a size increased by 
approximately 30 nm to a final diameter of approximately 50 nm. The electron density around the 
periphery of the particle is notably less, likely corresponding to the presence of the polymer and protein 
network. 
 
The magnitude of the observed growth is expected because the sizes of both the 
polymer and SAv protein are approximately equal to 29 nm. The observed size is within 
the error limits of the ideal increase in diameter (estimated by summing the length of the 
polymer and protein, respectively). Thermogenic analysis revealed a small decrease (-
0.006°C sec-1g1) in the thermal energy released by the SPION. This was likely due to the 
polymer and protein increasing drag (thus decreasing rotation frequency) in the aqueous 
medium. 
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 The initial part of this work involved the development and optimization of a novel 
nanotherapeutic complex. This endeavor began by optimizing a previously described 
electrochemical method for synthesizing SPIONs. Through thermogenic and VSM 
analysis, an optimal size of 21 nm was elucidated. The surface of this optimally sized 
particle was decorated though the addition of both a polymer and a GBM-targeting 
molecule (known as TWEAK). The presence of TWEAK on the SPION was confirmed 
via fluorescence spectroscopy. Following development of the SPION-TWEAK nano-
complex, its ability to selectively target and induce programmed cell death in U87 GBM 
cells was carried out in vitro with exciting and promising cytotoxic and specificity 
results. 
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In vitro testing: U87 GBM Studies 
To test the in vitro effects of the SPION-TWEAK nano-complex, GBM cells were 
grown onto coverslips modified for optical microscopy by adding the inverted BEEM 
capsules. The cells were then treated with either doxorubicin (DOX; the positive control), 
sterile PBS (the negative control), or SPION-TWEAK complexes. During the mid-to-late 
stages of programmed cell death, cells signal macrophages for phagocytosis by 
upregulating the concentration of phosphatidylserine (PS) at the external cell 
membrane.48 Annexin V is a human anticoagulant Ca2+-dependent phospholipid binding 
protein with a high affinity for PS. Thus, fluorescein-conjugated Annexin V (FITC-
Annexin V) gives a reliable method for detecting cells marked for programmed cell 
death. Propidium iodide (PI) is a heterocyclic aromatic fluorophore that is typically 
impermeable to live cells. The molecular structure of this fluorophore is seen in figure 21.  
 
Figure 21: The molecular structure of propidium iodide: a fluorophore that was used to detect cell death. 
 
 
In dead cells with a denatured external cell membrane, the fluorophore is able to 
diffuse into the nucleus and intercalate with DNA. Figure 22 shows the positive and 
negative controls of Annexin V/propidium iodide staining, respectively. Positive controls 
were treated with cytotoxic concentrations of DOX and negative controls were treated 
with equimolar amounts of PBS. 
 53 
 
Figure 22: U87 GBM cells were treated with either cytotoxic amounts of the apoptotic agent doxorubicin 
(a/b) or equimolar amounts of PBS (c/d), each for 6 hours, with the former being classified as the positive 
control for programmed cell death and the latter the negative control. 
 
 
As figure 22 shows, significant green fluorescence emission is noted in cells treated with 
DOX, particularly around the periphery of the cell. This indicates that there is an 
externalization of PS at the external cell membrane. In addition, the red fluorescence 
emission in figure 22 (a) is indicative of PI intercalating with the DNA in the nucleus of 
the cell. Morphologically, the cell of interest appears shrunken and blebbed (figure 22 
a 
 
b 
 
d 
 
c 
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(b)), all consistent with the mid-to-late stages of programmed cell death. Neither of these 
fluorescence signals are seen in the negative control treatment of cells with PBS (as 
expected) (figures 22 (c)/22 (d)). 
 Figure 22 shows that the fluorescence dyes of choice perform well in 
discriminating cells that show biochemical signs of programmed cell death against those 
that do not. The same fluorophores were then used to assess for cellular death in GBM 
cells following exposure to SPION-TWEAK nano-complexes over a period of 3 hours in 
a constant low energy (21 mT) magnetic field. The results, shown in figure 23, show a 
clear and distinct trend towards cell death within the experimental timeframe. 
 
Figure 23. Respective white light and fluorescence images of cells exposed to TWEAK-conjugated 
SPIONs for 20 minutes (a/b), 100 minutes (c/d), 2 hours (e/f), and 3 hours (g/h). From these images cells 
exposed to SPIONs undergo cell death through an apoptotic mechanism within 180 minutes following 
exposure to SPIONs. The size bar is 10 µm in all cases. 
 
 
At 20 minutes of SPION exposure, no significant, morphologically relevant fluorescence 
emission is visualized (figure 23 (a)/23 (b)). Individual cells begin fluorescing after 
approximately 90-100 minutes of SPION exposure, and their morphology appears 
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blebbed, all consistent with the cells being in the late stages of apoptosis (figure 23 (c)/23 
(d)). At 2 hours, red and green emission is seen simultaneously within the same cells, 
indicating that cell death has occurred (figure 23 (f)). At 3 hours, much of the 
fluorescence emission observed is red, indicating that most cells in this image are likely 
dead. Figure 23 provides evidence that SPION-TWEAK nano-complexes are able to 
initiate programmed cell death approximately 60-90 minutes following initial deposition. 
This timeline is similar to what has been previously reported by both He et al. and Yue et 
al. in their studies of the time-dependent SPION-induced programmed cell death of GBM 
cells.39,40 
 To further explore the capabilities of SPION-TWEAK complexes to induce 
programmed cell death in the presence of a magnetic field, TEM was performed to both 
track particle internalization and analyze subsequent cellular morphology. To halt SPION 
internalization and any subsequent cellular interactions, the GBM cells were immersed in 
a fixative solution following relevant durations of time (20 minutes, 100 minutes, 2 
hours, and 3 hours). The TEM studies, shown in figure 24, show that SPIONs internalize 
into the cell within 20 minutes of exposure (figure 24 (b)). Their presence in vesicles is 
apparent at least over the next 80 minutes (figure 24 (c)). Interestingly, at 100 minutes of 
cellular exposure, the average SPION diameter has notably decreased from 50 nm to 
approximately 15 nm. The nature of this decrease in size has not been fully elucidated 
and is the subject of future work. Cells exposed to SPIONs for 2 hours begin to show 
SPION accumulation in both the mitochondria (figure 24 (d)) and the nucleus (not 
shown), and at 3 hours of exposure the cells show heterogenous breakdown of the 
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chromatin, nuclear envelope, and large vacuole formation, all signs consistent with the 
late stages of programmed cell death.48,49 
 
 
Figure 24: Images taken via TEM of GBM cells. Healthy GBM cells display a morphologically intact 
nucleus with condensed chromatin and intact organelles (a; size bar 500 nm). After 20 minutes of SPION 
exposure, the nanoparticles are seen internalizing into the cell and are trapped in vesicles (b; size bar 20 
nm). At 100 minutes (c; size bar 100 nm), SPIONs are still trapped in well-formed vesicles, though 
distinctly smaller than their known size at this point ( 𝑥=15 nm). Cells exposed to SPIONs for 2 hours 
begin to show nanoparticle accumulation in organelles such as the mitochondria (d) and nucleus (not 
shown). By the third hour, nuclear envelope and chromatin breakdown along with large vacuole formation 
are visualized; all consistent with programmed cell death (e/f; size bar 100 nm and 500 nm, respectively). 
 
 
Following these results, the SPION-TWEAK complexes were tested against other types 
of cell lines to ensure that the SPIONs were specific to only GBM cells. This was 
accomplished by incubating the SPION-TWEAK complexes with Jurkat T-lymphocytes 
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over the course of three hours. DOX and PBS again acted as the positive and negative 
controls, respectively. Fluorescence microscopy was then performed as previously 
described, and the resultant images are seen in figure 25. 
 
 
 
 
 
 
Figure 25: Jurkat T-lymphocytes were incubated with either Doxorubicin (a/b), PBS (c/d), or SPION-
TWEAK complexes (e/f). Minimal phosphatidylserine upregulation was noted in both the negative control 
and in the SPION-TWEAK samples while the positive control exhibited both increased phosphatidylserine 
expression and propidium iodide intercalation within the nucleus. 
 
 
From figure 25 it is clear that the SPION-TWEAK complexes did not produce gross cell 
death as they did in the U87 GBM cells. In fact, only 1 cell out of the 20 exposed to 
SPION-TWEAK complexes showed biochemical evidence of upregulated PS at the 
external cell membrane, and no cells showed evidence of PI nuclear intercalation (figure 
25 (f)). The dramatic difference in the capabilities of SPION-TWEAK to produce cellular 
death in GBM versus Jurkat T-Lymphocytes likely stems from the fact that the SPIONs 
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negligibly internalize into the lymphocyte cell line as these cells do not express the Fn14 
receptor that TWEAK is a ligand for.50 In fact, within the environment of the central 
nervous system no cells aside from late stage neoplastic glial cells (such as GBM) 
substantially express the Fn14 receptor at the external membrane.6,38 Since non-neoplastic 
cells glial and neuronal cells are related to Jurkat T-lymphocytes in that both types of 
cells lack the Fn14 receptor, it is hypothesized that a similar result of no detectable 
programmed cell death would occur in the healthy parenchymal cells; however, proving 
this experimentally is the subject of future work. 
Conclusion: 
Glioblastoma Multiforme is regarded to many within the medical community as 
nature’s deadliest brain cancer. This work describes the novel synthesis of a SPION-
TWEAK nano-complex for targeted induction of programmed cell death of glioblastoma 
cells. By employing a novel time-dependent approach on a previously described 
electrochemical synthesis, an optimal particle size was afforded that released maximal 
amounts of heat following excitation with a low energy magnetic field. The final SPION-
TWEAK nano-complex was tested against both U87 Glioblastoma Multiforme cells and 
Jurkat T-Lymphocytes, and, utilizing a combination of fluorescence and transmission 
electron microscopy, sufficient biochemical and morphological evidence was gathered to 
assert that the SPION-TWEAK nano-complexes were able to induce programmed cell 
death exclusively in cells that express Fn14 at the external cell membrane.  
From this promising in vitro data we hope to gather more data regarding how the 
SPION-TWEAK complex induces death. Particularly, exploring the loss of mitochondrial 
membrane depolarization, which would indicate a loss of the ability to synthesize ATP is 
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of interest. Additionally, we hope to expand this therapy to an ex vivo model where 
nanoparticle internalization is analyzed in the environment of the tumor 
microenvironment. The destruction of cellular organelles would make programmed cell 
death of the invasive rim cells inevitable and irrevocable. In the GBM patient, this would 
increase disease survival and improved long-term prognoses. 
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Education 
George Washington University School of Medicine   Washington, D.C. 
• METEOR Research Fellow 
• Accepted June 2017 via Early Selection Agreement 
• Doctor of Medicine, Anticipated May 2023 
University of Mary Washington     Fredericksburg, VA 
• B.S. Biochemistry, Anticipated May 2019 
o ACS Approved Chemistry Curriculum 
• University Honor’s Scholar 
• Departmental Honors in Biochemistry 
Grants, Awards, and Accomplishments 
IAC Outstanding Biochemistry Award 2019 
Chi Beta Phi Senior Key Award 2019 
SURC Outstanding Oral Presentation 2019 
Naval HPSP 4 Year Scholarship Recipient 2018 
Chi Beta Phi National Meeting 1st Place in Undergraduate Research 
ACS National Meeting Outstanding Undergraduate Research Poster 
Earl G. Insley Chi Beta Phi Scholarship 
2018 
2018 
2018 
Irene Piscopo Rodgers Research Fellowship II  2018 
First UMW student accepted to GWU School of Medicine Early 
Acceptance Program  
2017 
Irene Piscopo Rodgers Research Fellowship I  2017-2018 
University Undergraduate Research Grant 2016-2017 
P. Sukalo and J. Boarman Award 2016-2017 
University Deans list (x5) 2015-2017 
University President’s List Fall 2016 
Eagle Scout 2014 
Research Experience 
Principal Undergraduate Researcher  
The University of Mary Washington                                           Fredericksburg, VA 2018-
Present 
Adviser: Dr. Robert Wells, Ph.D. 
Analyzing the Neurobiological Connections Between Musical Chord Structures and 
Emotion 
 64 
-Novel connections were made between the physical phenomena of acoustics, 
the biological phenomena of auditory sensation, and common musical chord 
structures seen in westernized music. 
-Work culminated in the assembly of a senior-level research dissertation. 
 
Principal Undergraduate Researcher  
The University of Mary Washington                                           Fredericksburg, VA 2016-
Present 
Adviser: Dr. Leanna Giancarlo, Ph.D. 
Synthesis of a Superparamagnetic Iron Oxide Based Nano-complex for Targeted Cell 
Death of Glioblastoma Cells 
-A novel synthetic method was utilized and optimized to create magnetic 
nanoparticles with optimal thermogenic properties. These optimized 
nanoparticles were bio-conjugated through the addition of a PEG-based polymer 
and a cancer targeting peptide. 
- Transmission electron microscopy confirmed that the nanoparticles were 
selectively endocytosed into Glioblastoma cells. Epifluorescence microscopy was 
utilized to confirm that the nano-complexes induced apoptosis after 
approximately 3 hours of cellular exposure.  
-Acquired merit-based funding through the Irene Piscopo Rodgers Research 
fellowship. 
-Assembled and managed a research team consisting of 5 unpaid undergraduate 
students. 
-An informal cross-institutional partnership was formed between George 
Washington University’s Magnetics Research Lab and my research group was 
formed. In this partnership, a post-doctoral fellow was recruited via a material-
for-service trade where I purchased his instrument parts and he ran magnetic 
hysteresis tests on my samples. 
-Presented results at 10+ conferences; one manuscript submitted for 
publication; one departmental honors dissertation prepared and defended. 
Assistant Undergraduate Researcher  
The University of Mary Washington      Fredericksburg, VA 
2015-16 
Adviser: Dr. Lynn Lewis, Ph.D.             
Characterizing Di’ildio: A unique syphoviridae bacteriophage 
 65 
-A novel, unique bacteriophage was isolated from the bacterium Bacillus. 
thuringiensis subspecies Berliner DSM 350 that originally came from a soil 
sample collected in Fredericksburg, Virginia. Transmission electron microscopy, 
polymerase chain reactions, gel electrophoresis, primer synthesis, and 
bioinformatic software was used to characterize the bacteriophage. 
-Operated as a member of a three-person team, to include one other 
undergraduate student and a professor. 
Professional Associations 
Phi Beta Kappa Academic Honor Society 
American Chemical Society (University Faculty Liaison Officer 2017-2018) 
Chi Beta Phi STEM Honor Society (Society President 2017-2018; Society Senior Advisor 
2019) 
Phi Eta Sigma Academic Honor Society 
Publications 
Tovar, M.; Parkhurst, A.; Matuczinski, E.; Balenger, S.; Giancarlo, L.C. Synthesis of a 
Superparamagnetic Iron Oxide Based Nano-complex for Targeted Cell Death of 
Glioblastoma Cells. Nanotechnology (IOP). Submitted for Publication. 
Tovar, M. Undergraduate Departmental Honors Thesis, The University of Mary 
Washington, Fredericksburg, VA, 05/11/2019. 
Selected Conference Presentations 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Virginia Collegiate Honors 
Council. Presentation. March, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. ACS National Conference, 
2019. Poster. March, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Southern Undergarduate 
Research Conference. Presentation. February, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Southern Undergarduate 
Research Conference. Presentation. February, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Chi Beta Phi National 
Conference. Presentation. November, 2018. 
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Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. National Collegiate Honor’s 
Council National Conference. Poster. August, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Chi Beta Phi National Science 
Honorary National Conference. Poster. October, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. American Chemical Society 
National Conference. Poster. August, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Virginia Academy of Science 
State Conference. Research Talk delivered May, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Southern Regional Honors 
Conference. Research Talk delivered April, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Southeastern Undergraduate 
Research Conference. Research Talk delivered February, 2018. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Chi Beta Phi National 
Conference. Research Talk delivered November 2017. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Virginia ACS Poster 
Conference. Poster, April 2017. 
Tovar, M. Electrochemical Synthesis and Optimization of Magnetic Nanoparticle to 
Induce Cell-Specific Apoptosis in Metastatic Glioblastoma. Virginia Collegiate Honor’s 
Council. Poster, April 2017. 
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Clinical Experience 
Emergency Room Medical Scribe      2016-Present 
 Mary Washington Hospital, Stafford Hospital  
 Fredericksburg, VA 
-Assisted physicians and PAs with documentation by conducting patient 
interviews, recording procedures, and reviewing charts. 
-Provided additional miscellaneous clerical support for medical providers.  
Emergency Room Technician       2015-2016 
 Stafford Hospital       Stafford, VA 
-Provided patient care in a high-volume patient environment with a wide variety 
of medical and traumatic emergencies. 
-Worked as a member of the code team in resuscitating adult, pediatric, and 
neonatal patients. 
-Administered emergent diagnostic tests to patients upon orders of physician 
including administration and interpretation of 12-Lead EKG’s, urine and blood 
analysis tests, and rapid radiological studies. 
-Performed medical procedures including sterile catheterization and setting 
fractures bones in temporary fiberglass casts. 
-Assisted nurses in triaging patient acuity. 
-Assisted in various emergent medical procedures such as laceration repair, 
reducing complex fractures, emergency thoracenteses, cricothyrotomies, rapid 
sequence intubation, and emergent anesthesia administration. 
Emergency Medical Technician      2014-Present 
Stafford County Fire and Rescue     Stafford, VA 
-Operated as a member of a 2-3-person fire and rescue team. Independently 
provided basic life support and assisted paramedics in providing advanced life 
support medical care to patients suffering from acute medical emergencies. 
References 
Dr. Leanna Giancarlo, PhD. Associate Professor of Chemistry. Department of Chemistry, 
University of Mary Washington, Fredericksburg, VA 22401. 540-654-1407. 
lgiancar@umw.edu. 
Dr. Kelli Slunt, PhD. Professor of Chemistry. Department of Chemistry, University of 
Mary Washington, Fredericksburg, VA 22401, 540.654.1406. kslunt@umw.edu 
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Dr. Agostino Visioni, M.D. Attending Neurosurgeron. Mary Washington Medical Group 
Neurosurgery. dvisioni@hotmail.com 
 
